Objective To study the clinical value of the quantities and the activity of tissue factor pathway inhibitor(TFPI)on carcinoma of endometrium.

• 目的研究血浆组织因子途径抑制物(TFPI)抗原含量及活性对子宫内膜癌患者的临床意义。